These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35581577)

  • 1. Comparison of reader agreement, correlation with liver biopsy, and time-burden sampling strategies for liver proton density fat fraction measured using magnetic resonance imaging in patients with obesity: a secondary cross-sectional study.
    Cao D; Li M; Liu Y; Jin H; Yang D; Xu H; Lv H; Liu J; Zhang P; Zhang Z; Yang Z
    BMC Med Imaging; 2022 May; 22(1):92. PubMed ID: 35581577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis.
    Hooker JC; Hamilton G; Park CC; Liao S; Wolfson T; Dehkordy SF; Hong CW; Mamidipalli A; Gamst A; Loomba R; Sirlin CB
    Abdom Radiol (NY); 2019 Feb; 44(2):482-492. PubMed ID: 30128694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification.
    Hong CW; Wolfson T; Sy EZ; Schlein AN; Hooker JC; Fazeli Dehkordy S; Hamilton G; Reeder SB; Loomba R; Sirlin CB
    J Magn Reson Imaging; 2018 Apr; 47(4):988-994. PubMed ID: 28842937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes.
    Vu KN; Gilbert G; Chalut M; Chagnon M; Chartrand G; Tang A
    J Magn Reson Imaging; 2016 May; 43(5):1090-9. PubMed ID: 26536609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeatability and accuracy of various region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification.
    Hong CW; Cui JY; Batakis D; Xu Y; Wolfson T; Gamst AC; Schlein AN; Negrete LM; Middleton MS; Hamilton G; Loomba R; Schwimmer JB; Fowler KJ; Sirlin CB
    Abdom Radiol (NY); 2021 Jul; 46(7):3105-3116. PubMed ID: 33609166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized Approach for ROI-Based Measurements of Proton Density Fat Fraction and R2* in the Liver.
    Campo CA; Hernando D; Schubert T; Bookwalter CA; Pay AJV; Reeder SB
    AJR Am J Roentgenol; 2017 Sep; 209(3):592-603. PubMed ID: 28705058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
    Martí-Aguado D; Jiménez-Pastor A; Alberich-Bayarri Á; Rodríguez-Ortega A; Alfaro-Cervello C; Mestre-Alagarda C; Bauza M; Gallén-Peris A; Valero-Pérez E; Ballester MP; Gimeno-Torres M; Pérez-Girbés A; Benlloch S; Pérez-Rojas J; Puglia V; Ferrández A; Aguilera V; Escudero-García D; Serra MA; Martí-Bonmatí L
    Radiology; 2022 Feb; 302(2):345-354. PubMed ID: 34783592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective comparison of liver chemical shift-encoded PDFF sampling strategies in children and adolescents.
    de Padua V Alves V; Dillman JR; Trout AT
    Abdom Radiol (NY); 2022 Oct; 47(10):3478-3484. PubMed ID: 35864263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of PDFF estimation by magnitude-based and complex-based MRI in children with MR spectroscopy as a reference.
    Haufe WM; Wolfson T; Hooker CA; Hooker JC; Covarrubias Y; Schlein AN; Hamilton G; Middleton MS; Angeles JE; Hernando D; Reeder SB; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2017 Dec; 46(6):1641-1647. PubMed ID: 28323377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults.
    Tyagi A; Yeganeh O; Levin Y; Hooker JC; Hamilton GC; Wolfson T; Gamst A; Zand AK; Heba E; Loomba R; Schwimmer J; Middleton MS; Sirlin CB
    Abdom Imaging; 2015 Oct; 40(8):3070-7. PubMed ID: 26350282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis.
    Mamidipalli A; Hamilton G; Manning P; Hong CW; Park CC; Wolfson T; Hooker J; Heba E; Schlein A; Gamst A; Durelle J; Paiz M; Middleton MS; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2018 Feb; 47(2):418-424. PubMed ID: 28543915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement between region-of-interest- and parametric map-based hepatic proton density fat fraction estimation in adults with chronic liver disease.
    Manning PM; Hamilton G; Wang K; Park C; Hooker JC; Wolfson T; Gamst A; Haufe WM; Schlein AN; Middleton MS; Sirlin CB
    Abdom Radiol (NY); 2017 Mar; 42(3):833-841. PubMed ID: 27688063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial distribution of MRI-Determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease.
    Bonekamp S; Tang A; Mashhood A; Wolfson T; Changchien C; Middleton MS; Clark L; Gamst A; Loomba R; Sirlin CB
    J Magn Reson Imaging; 2014 Jun; 39(6):1525-32. PubMed ID: 24987758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C).
    Mamidipalli A; Fowler KJ; Hamilton G; Wolfson T; Covarrubias Y; Tran C; Fazeli S; Wiens CN; McMillan A; Artz NS; Funk LM; Campos GM; Greenberg JA; Gamst A; Middleton MS; Schwimmer JB; Reeder SB; Sirlin CB
    Eur Radiol; 2020 Sep; 30(9):5120-5129. PubMed ID: 32318847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.
    Bannas P; Kramer H; Hernando D; Agni R; Cunningham AM; Mandal R; Motosugi U; Sharma SD; Munoz del Rio A; Fernandez L; Reeder SB
    Hepatology; 2015 Nov; 62(5):1444-55. PubMed ID: 26224591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between magnetic resonance imaging proton density fat fraction (MRI-PDFF) and liver biopsy to assess hepatic steatosis in obesity.
    Wibulpolprasert P; Subpinyo B; Chirnaksorn S; Shantavasinkul PC; Putadechakum S; Phongkitkarun S; Sritara C; Angkathunyakul N; Sumritpradit P
    Sci Rep; 2024 Mar; 14(1):6895. PubMed ID: 38519637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CNN color-coded difference maps accurately display longitudinal changes in liver MRI-PDFF.
    Hasenstab K; Cunha GM; Ichikawa S; Dehkordy SF; Lee MH; Kim SJ; Schlein A; Covarrubias Y; Sirlin CB; Fowler KJ
    Eur Radiol; 2021 Jul; 31(7):5041-5049. PubMed ID: 33449180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep Learning for Inference of Hepatic Proton Density Fat Fraction From T1-Weighted In-Phase and Opposed-Phase MRI: Retrospective Analysis of Population-Based Trial Data.
    Wang K; Cunha GM; Hasenstab K; Henderson WC; Middleton MS; Cole SA; Umans JG; Ali T; Hsiao A; Sirlin CB
    AJR Am J Roentgenol; 2023 Nov; 221(5):620-631. PubMed ID: 37466189
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three segments sampling strategy for the assessment of liver steatosis using magnetic resonance imaging proton density fat fraction.
    Kim A; Kim M; Lee CM; Kang BK; Jun DW
    Eur J Radiol; 2023 Feb; 159():110653. PubMed ID: 36563563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.